What Families Actually Need: Rethinking Autism Care Tools

jessica-taverniti

In this episode of the EarliPoint Exchange, hosts Dr. Cheryl Tierney and Kirsten Yurich, BCBA, are joined by Dr. Jessica Taverniti, PsyD, BCBA-D, founder and CEO of NuroLux, for a candid conversation about what families navigating autism care truly need—and where current systems and tools often fall short. Drawing from her clinical background and entrepreneurial work, Dr. Taverniti shares how NuroLux was designed to help families make sense of complex information, prioritize next steps, and engage more confidently with care systems.

The discussion explores how data-driven assessments, thoughtful digital design, and ethical use of technology can move beyond information overload to deliver clarity, personalization, and practical guidance. This episode highlights the importance of aligning clinical rigor with lived experience to create tools that genuinely support families, improve care coordination, and enhance outcomes across the autism care continuum.

The webinar will be held on February 25, 2026, from 1:00 AM to 2:00 AM PST, and includes 1 BACB Learning CEU. Attendance is included free with a BehaviorLive subscription, and registrants will also have access to the recorded session on-demand for CEUs.

Learning Objectives

  • Identify common gaps between existing autism care tools and the real-world needs of families navigating diagnosis, services, and ongoing care.
  • Describe how data-informed, family-centered tools can translate complex clinical information into actionable guidance that supports decision-making and care planning.
  • Discuss key principles for designing ethical, effective technology solutions that improve engagement, coordination, and support for families impacted by autism.

Register now to reserve your spot and explore how groundbreaking research in eye-tracking is advancing the future of autism diagnosis and assessment.

Latest News

See how EarliPoint fits seamlessly into your clinical workflow.

Jamie Pagliaro brings over two decades of leadership in autism and behavioral health to his role as President and CEO of EarliPoint. Most recently, he served as Chief Operating Officer at Rethink, a leading SaaS provider supporting individuals with autism and developmental disabilities. Under his leadership, Rethink’s behavioral health division became the company’s largest business unit, serving thousands of clinicians and driving scalable, tech-enabled care delivery.

Earlier in his career, Jamie was Executive Director of the New York Center for Autism Charter School, the first public charter school in New York State dedicated to children with autism. At EarliPoint, he leads the company’s mission to bring breakthrough science to the front lines of care—empowering providers, families, and health systems with earlier answers and better outcomes.

Jamie Pagliaro

President & Chief Executive Officer

Dr. Ami Klin is a globally recognized leader in autism research and early detection. As Director of the Marcus Autism Center and Division Chief of Autism and Developmental Disabilities at Emory University School of Medicine, he has dedicated his career to understanding how young children engage with the social world—and how subtle disruptions in attention can signal developmental differences. His pioneering work in eye-tracking science led to the development of EarliPoint™ Evaluation, the first FDA-authorized tool to objectively assess autism in children as young as 16 months.
At EarliPoint, Dr. Klin drives clinical strategy and innovation, ensuring that families and clinicians worldwide have access to timely, science-based insights that enable earlier, more personalized intervention. His career reflects a deep commitment to transforming how society supports children with autism—starting with the earliest signs.

Ami Klin, PhD

Chief Clinical Officer & Co‑Founder